Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

SI-BONE, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

ACHIEVED ~22% WORLDWIDE REVENUE GROWTH, POSITIVE ADJUSTED EBITDA AND CASH FLOW BREAKEVEN ACHIEVED ~22% WORLDWIDE REVENUE GROWTH, POSITIVE ADJUSTED EBITDA AND CASH FLOW BREAKEVEN

SI-BONE, INC. REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER 2025 AND RAISES 2025 GUIDANCE

SANTA CLARA, CALIF., JULY 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY DEDICATED TO SOLVING SACROPELVIC DISORDERS, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING CANACCORD GENUITY 45TH ANNUAL GROWTH CONFERENCE IN BOSTON, MA. MANAGEMENT WILL BE HOSTING A FIRESIDE CHAT ON TUESDAY, AUGUST 12, 2025, AT 12:00 P.M. PACIFIC TIME/03:00 P.M. EASTERN TIME.

SI-BONE TO PRESENT AT CANACCORD GENUITY 45TH ANNUAL GROWTH CONFERENCE ON AUGUST 12, 2025

SANTA CLARA, CALIF., JULY 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY DEDICATED TO SOLVING SACROPELVIC DISORDERS, TODAY ANNOUNCED IT WILL REPORT FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2025 AFTER MARKET CLOSE ON MONDAY, AUGUST 4, 2025. MANAGEMENT WILL HOST A CONFERENCE CALL BEGINNING AT 1:30 P.M. PACIFIC TIME / 4:30 P.M. EASTERN TIME.

SI-BONE TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 4, 2025

SANTA CLARA, CALIF., JUNE 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY DEDICATED TO SOLVING SACROPELVIC DISORDERS, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING 2025 TRUIST SECURITIES MEDTECH CONFERENCE IN BOSTON, MA. MANAGEMENT WILL BE HOSTING A FIRESIDE CHAT ON TUESDAY, JUNE 17, 2025, AT 10:00 A.M. PACIFIC TIME/1:00 P.M. EASTERN TIME.

SI-BONE TO TRUIST SECURITIES MEDTECH CONFERENCE ON JUNE 17, 2025

SANTA CLARA, CALIF., JUNE 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY DEDICATED TO SOLVING SACROPELVIC DISORDERS, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING 2025 TRUIST SECURITIES MEDTECH CONFERENCE IN BOSTON, MA.

SI-BONE TO PRESENT AT TRUIST SECURITIES MEDTECH CONFERENCE ON JUNE 17, 2025

SANTA CLARA, CALIF., MAY 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY DEDICATED TO SOLVING SACROPELVIC DISORDERS, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING 2025 GOLDMAN SACHS 46TH GLOBAL HEALTHCARE CONFERENCE IN MIAMI BEACH, FL. MANAGEMENT WILL BE HOSTING A FIRESIDE CHAT ON TUESDAY, JUNE 10, 2025, AT 8:20 A.M. PACIFIC TIME/11:20 A.M. EASTERN TIME.

SI-BONE TO PRESENT AT GOLDMAN SACHS 46TH GLOBAL HEALTHCARE CONFERENCE ON JUNE 10, 2025

SANTA CLARA, CALIF., MAY 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY DEDICATED TO SOLVING SACROPELVIC DISORDERS, TODAY ANNOUNCED THAT THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING 2025 BOFA SECURITIES HEALTHCARE CONFERENCE IN LAS VEGAS. MANAGEMENT WILL BE HOSTING A FIRESIDE CHAT ON TUESDAY, MAY 13, 2025, AT 8:40 A.M. PACIFIC TIME/11:40 A.M. EASTERN TIME.

SI-BONE TO PRESENT AT BOFA SECURITIES 2025 HEALTHCARE CONFERENCE ON MAY 13, 2025

FIRST QUARTER 2025 FINANCIAL HIGHLIGHTS (ALL COMPARISONS ARE TO THE PRIOR YEAR PERIOD) WORLDWIDE REVENUE OF $47.3 MILLION, REPRESENTING GROWTH OF 24.9% U.S. REVENUE OF $44.8 MILLION, REPRESENTING GROWTH OF 26.6% GROSS MARGIN OF 79.7%, REPRESENTING AN IMPROVEMENT OF 80 BASIS POINTS NET LOSS OF $6.5 MILLION, REPRESENTING AN IMPROVEMENT OF 40.0% POSITIVE ADJUSTED EBITDA OF $0.5 MILLION $144.4 MILLION IN CASH AND EQUIVALENTS, WITH NET CASH USAGE IN THE QUARTER DECLINING 31.7% TO $5.6 MILLION RECENT OPERATIONAL HIGHLIGHTS (ANY COMPARISONS ARE TO THE PRIOR YEAR PERIOD) OVER 1,400 ACTIVE U.S. PHYSICIANS WITH 300 PHYSICIANS ADDED IN THE QUARTER, REPRESENTING 27.3% GROWTH CMS FY 2026 PROPOSED HOSPITAL INPATIENT RULE FOR NEW TECHNOLOGY ADD-ON PAYMENT (NTAP) EFFECTIVE OCTOBER 1, 2025, PAYING AN ADDITIONAL AMOUNT UP TO $3,960 FOR PROCEDURES INVOLVING IFUSE TORQ TNT SANTA CLARA, CALIF., MAY 05, 2025 (GLOBE NEWSWIRE) -- SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY DEDICATED TO SOLVING SACROPELVIC DISORDERS, TODAY REPORTED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2025.

SI-BONE, INC. REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER 2025 AND UPDATES 2025 GUIDANCE

ACHIEVES 26% WORLDWIDE REVENUE GROWTH AND POSITIVE ADJUSTED EBITDA IN FOURTH QUARTER 2024 ACHIEVES 26% WORLDWIDE REVENUE GROWTH AND POSITIVE ADJUSTED EBITDA IN FOURTH QUARTER 2024

SI-BONE, INC. REPORTS RECORD FINANCIAL RESULTS FOR THE FOURTH QUARTER 2024 AND ISSUES 2025 GUIDANCE

BILLERICA, MASS.--(BUSINESS WIRE)---- $BRKR #BRKR--BRUKER CORPORATION (NASDAQ: BRKR) TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS APPOINTED LAURA FRANCIS TO SERVE ON ITS BOARD AS AN INDEPENDENT DIRECTOR, EFFECTIVE AS OF FEBRUARY 18, 2025. MS. FRANCIS IS ALSO EXPECTED TO JOIN BRUKER'S AUDIT COMMITTEE AS A FINANCIAL EXPERT AFTER BRUKER'S ANNUAL SHAREHOLDER MEETING AT THE END OF MAY 2025. LAURA FRANCIS IS THE CHIEF EXECUTIVE OFFICER AND A BOARD MEMBER OF SI-BONE, INC. (NASDAQ: SIBN), A MEDICAL DEVICE COMPANY S.

SI-BONE, Inc.

SIBN

Price

Financials Overview

Financial Reports

No items found.

Press Releases

SI-BONE, Inc.

SIBN.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

SIBN